RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway
RERE-AS1通过MEK/ERK通路增强CDK4/6抑制剂瑞博西尼的作用,并抑制乳腺癌的恶性表型。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05828-x
Huang, Zhidong; Lou, Kaixin; Qi, Mengyang; Wang, Jinhui; Li, Linwei; Sun, Bo; Wang, Chen; Zhou, Xirui; Chen, Debo; Liu, Hong
CDK4
肿瘤
RERE
肿瘤免疫
信号转导
乳腺癌
MAPK/ERK